Point-of-care measurement of C-reactive protein promotes de-escalation of treatment decisions and strengthens the perceived clinical confidence of physicians in out-of-hours outpatient emergency medical services.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
05 05 2023
Historique:
medline: 8 5 2023
pubmed: 6 5 2023
entrez: 5 5 2023
Statut: epublish

Résumé

Out-of-hours outpatient emergency medical services (OEMS) provide healthcare for patients with non-life-threatening conditions in need for urgent care when outpatient practices are closed. We studied the use of point-of-care-testing of C-reactive protein (CRP-POCT) at OEMS. Cross-sectional questionnaire-based survey. Single centre OEMS practice in Hildesheim, Germany (October 2021 to March 2022). OEMS physicians answering a questionnaire immediately after performing CRP-POCTs (CUBE-S Analyzer, Hitado) on any patients. Impact of CRP-POCTs on clinical decision-making and perceived usefulness. In the 6-month study period, 114 valid CRP-POCTs were performed in the OEMS practice by 18 physicians and the questionnaire was answered in 112 cases (response rate: 98.2%). CRP-POCTs were used in the diagnosis of inflammatory diseases of the gastrointestinal tract (60.0%), respiratory tract infections (17.0%), urinary tract infections (9.0%) and other non-gastrointestinal/non-specified infections (11.0%). The use of a CRP-POCT resulted in a change of the physicians' clinical decision in 83.3% of the cases. Specifically, in 13.6% and 35.1% of the cases, rapid CRP measurements led to decision changes in the (1) initiation of antimicrobial therapy and (2) other drug treatment, respectively. Notably, in 60% of all cases, the use of a CRP-POCT reportedly changed the decision on hospitalisation/non-hospitalisation of OEMS patients. In respect of antimicrobial therapy and hospitalisation, these decision changes primarily (≥73%) promoted 'step-down' decisions, that is, no antibiotic therapy and no hospital admission. In the great majority of CRP-POCT applications (≥95%), OEMS physicians reported that rapid CRP measurements increased the confidence in their diagnostic and therapeutic decision. In almost all cases (97%), physicians rated the CRP-POCT use as useful in the treatment situation. Quantitative CRP-POCT promotes step-down clinical decisions and strengthens the clinical confidence of physicians in out-of-hours OEMS.

Identifiants

pubmed: 37147098
pii: bmjopen-2022-069453
doi: 10.1136/bmjopen-2022-069453
pmc: PMC10163444
doi:

Substances chimiques

C-Reactive Protein 9007-41-4

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e069453

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Lancet Reg Health Eur. 2021 Jul;6:100112
pubmed: 34124707
Pediatr Int. 2014 Oct;56(5):698-701
pubmed: 24689910
J Biomark. 2015;2015:519534
pubmed: 26345247
Nat Clin Pract Gastroenterol Hepatol. 2005 Dec;2(12):580-6
pubmed: 16327837
Dtsch Arztebl Int. 2010 Aug;107(33):561-7
pubmed: 20830271
Front Immunol. 2018 Apr 13;9:754
pubmed: 29706967
Br J Gen Pract. 2020 Jun 25;70(696):e505-e513
pubmed: 32424045
BMJ. 2021 Sep 21;374:n2198
pubmed: 34548288
Int J Colorectal Dis. 2017 Oct;32(10):1375-1383
pubmed: 28799055
Antibiotics (Basel). 2020 Sep 16;9(9):
pubmed: 32948060
Trends Analyt Chem. 2011 Jun;30(6):887-898
pubmed: 32287536
J Clin Gastroenterol. 2016 Oct;50 Suppl 1:S26-8
pubmed: 27622356
Laryngorhinootologie. 2022 May;101(5):414-418
pubmed: 34130328
Adv Data. 2007 Jun 29;(387):1-39
pubmed: 17703793
Int J Surg. 2004;2(2):88-9
pubmed: 17462226
Am J Emerg Med. 2020 Apr;38(4):774-779
pubmed: 31288959
Pediatr Emerg Care. 2015 Sep;31(9):633-9
pubmed: 26181498
BMC Prim Care. 2023 Apr 11;24(1):96
pubmed: 37038122
J Clin Epidemiol. 2008 Apr;61(4):344-9
pubmed: 18313558
Br J Surg. 2013 Feb;100(3):322-9
pubmed: 23203918
Anaesthesist. 2019 Nov;68(11):762-769
pubmed: 31690959
Z Evid Fortbild Qual Gesundhwes. 2022 Nov;174:1-10
pubmed: 36055890
Arch Dis Child. 2018 May;103(5):420-426
pubmed: 29269559
ANZ J Surg. 2020 Oct;90(10):1970-1974
pubmed: 31721396
BMJ Open. 2017 Aug 29;7(8):e011543
pubmed: 28851767
Cochrane Database Syst Rev. 2022 Oct 17;10:CD010130
pubmed: 36250577
J Med Virol. 2022 Jan;94(1):298-302
pubmed: 34491581
Scand J Trauma Resusc Emerg Med. 2016 Oct 18;24(1):125
pubmed: 27756354
BMJ Open Qual. 2018 Oct 15;7(4):e000391
pubmed: 30397661

Auteurs

Anni Matthes (A)

Institute of General Practice and Family Medicine, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany.
InfectoGnostics Research Campus Jena, Jena, Germany.

Florian Wolf (F)

Institute of General Practice and Family Medicine, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany.

Elmar Wilde (E)

Practice Network HilMed Hildesheim, Hildesheim, Germany.

Jutta Bleidorn (J)

Institute of General Practice and Family Medicine, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany.

Robby Markwart (R)

Institute of General Practice and Family Medicine, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany robby.markwart@med.uni-jena.de.
InfectoGnostics Research Campus Jena, Jena, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH